You are viewing:
Information released online before January, 2021.
Note: Content in this archive site is NOT UPDATED, and external links may not function. External links to other Internet sites should not be construed as an endorsement of the views contained therein.
You are entering the 2017-2020 Archive for the
United States Agency for International Development web site.
If you are looking for current information, visit www.usaid.gov.
Tuberculosis (TB) closely follows HIV and malaria as a major cause of illness and mortality in Tanzania, which is among the 30 highest-burden countries for TB and TB/HIV coinfection. USAID’s tuberculosis strategy in Tanzania supports the National Tuberculosis and Leprosy Program (NTLP) to address systemic and operational challenges to preventing, detecting, and treating the disease. This includes improving access to quality, patient-centered care for TB, TB/HIV, and multidrug-resistant TB; preventing transmission and disease progression; and strengthening Tanzania’s TB platforms to reduce reliance on external financial and technical support.
Comment
Make a general inquiry or suggest an improvement.